100.940 articles found

Towards a Better Definition of Patient-Centered Therapeutic Strategy of Parkinson's Disease: An Opinion Paper.

Reichmann H, Antonini A, Chaudhuri KR, Danaila T, Devos D, Foltynie T, Jesús Maestre S, Jost WH, Kaasinen V, Katzenschlager R, López Manzanares L, Pagonabarraga Mora J, Santens P, Santos García D, Tamburin S, Winkler J, Rascol O.

Neurol Ther · 2026-10-13

DOI: 10.1007/s40120-026-01055-2PMID: 42870196

Antidepressant use and Parkinson's disease risk: Overall protective effect with drug-specific variation.

Baranova A, Cao H, Xu C, Sun W, Liu D, Zhang F.

Gen Psychiatr · 2026-10-13

DOI: 10.1002/gps3.70067PMID: 42871888

Sensor-derived turning measures for differentiating earlier-stage Parkinson's disease and characterizing motor severity.

Liu P, Wang Y, Jing X, Hou W, Wu F, Wu J.

Parkinsonism Relat Disord · 2026-10-13

DOI: 10.1016/j.parkreldis.2026.109016PMID: 42892007

Explainable machine learning of plantar-force gait biomarkers for Hoehn–Yahr staging in Parkinson’s disease

Yang M, Xiong X, Yuan W, Chen M, Zhongqiang L.

· 2026-10-12

DOI: 10.21203/rs.3.rs-10979628/v1

Application of Bayesian-Derived Gene Interaction Network and Subnetwork for Classification of Idiopathic Parkinson’s Disease with Biomarkers

Yang R, Yuan Y.

· 2026-10-12

DOI: 10.64898/2026.10.05.756343

Astrocyte-Specific dsRNA–ADAR1 Signalling Links Innate Immunity to Complement Activation in Parkinson’s Disease

Liu Y, Halliday GM, Fu Y.

· 2026-10-12

DOI: 10.64898/2026.10.06.757209

Disease Duration Differentiates Freezing of Gait Response to Subthalamic and Nigral Stimulation for Parkinson's Disease in an Exploratory Multicenter Controlled Trial

Weiss D, Cebi I, Schütt M, Fischer I, Pavelka L, Kolber P, Pötter‐Nerger M, Hamel W, Kühn A, Hartmann C, Bötzel K, Köglsperger T, Barbe M, Kohl Z, Paschen S, Hobert M, Groppa S, Warnecke T, Claus I, Krüger R, Gharabaghi A.

Movement disorders clinical practice · 2026-10-12

Targeting the Gut to Modify Parkinson's Disease: From Mechanisms to Potential Therapeutics.

Tai YC, Lin CH.

J Mov Disord · 2026-10-12

DOI: 10.14802/jmd.26285PMID: 42860646

Candidate neurobiological pathways linking physical exercise to cognition in Parkinson's disease: a hypothesis-generating translational framework.

Byun K, Lee JY, Kim R.

J Mov Disord · 2026-10-12

DOI: 10.14802/jmd.26260PMID: 42860647

Disease Duration Differentiates Freezing of Gait Response to Subthalamic and Nigral Stimulation for Parkinson's Disease in an Exploratory Multicenter Controlled Trial.

Weiss D, Cebi I, Schütt M, Fischer I, Pavelka L, Kolber P, Pötter-Nerger M, Hamel W, Kühn AA, Hartmann CJ, Bötzel K, Köglsperger T, Barbe MT, Kohl Z, Paschen S, Hobert MA, Groppa S, Warnecke T, Claus I, Krüger R, Gharabaghi A, Multicenter STN+SNr Study Group.

Mov Disord Clin Pract · 2026-10-12

DOI: 10.1002/mdc3.70813PMID: 42860886

Caregiver Burden and Its Determinants After Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease: A Cross-Sectional Long-Term Follow-Up Study.

Margarido I, Pacheco C, Ramos J, Chamadoira C, Rito M, Oliveira A, Rosas MJ, Ferreira-Pinto MJ, Soares C.

Mov Disord Clin Pract · 2026-10-12

DOI: 10.1002/mdc3.70851PMID: 42860906

Persistent Therapeutic Burden after Device-Aided Therapy in Parkinson's Disease: Insights from Post-DAT MANAGE-PD Assessment.

Onder H, Gültekin M, Yavuz Z, Çıplaklıgil A, Comoglu S.

Mov Disord Clin Pract · 2026-10-12

DOI: 10.1002/mdc3.70861PMID: 42860929